Long-term survival of primary penile cancer in a supra-regional centre : A1
Is pelvic lymph node dissection for pN2 penile cancer necessary? : A2
Outcome from radical lymphadenectomy (RL) for penile carcinoma - a contemporary series : A3
Early experience of the use of dynamic sentinel node biopsy in penile cancer patients with non-palpable inguinal nodes : A4
Penile cancer and the impact of penectomy or penile conserving surgery on perceptions of masculinity, quality of life and post-surgical psychological adjustment : A5
Treatment of carcinoma in-situ (CIS) of the penis with topical chemotherapy agents : A6
Do younger patients have more aggressive penile cancer? : A7
Oncological outcomes of glans resurfacing in the treatment of selected superficially invasive penile cancers : A8
BAUS section of Andrology and Genito- Urethral Surgery National Penile Cancer Audit: 5 year cancer specific survival of patients with suspected pelvic lymph node involvement : A9
Salvage microdissection testicular sperm extraction; outcome in men with Non obstructive azoospermia : A10
Diagnosis of bladder cancer by combined detection of minichromosome maintenance 5 protein and NMP22 in urine : B1
Detection and staging of bladder cancer by ‘OMIC’ analysis of urine : B2
Nuclear Matrix Protein-22 (NMP-22) for the diagnosis of urothelial cancer - a prospective study : B3
A prospective randomised trial of Hexylaminolevulinate (HAL) assisted transurethral resection (TURBT) plus single shot intravesical MitomycinC (MMC) versus white light TURBT plus single shot MMC in newly presenting bladder cancer : B4
Bipolar plasma vaporization and NBI in large non-muscle invasive bladder tumors - better than the standard approach : B5
Holmium: YAG laser treatment for superficial bladder carcinoma : B6
Recurrence at 1 year for non-muscle invasive bladder cancer (NMIBC) is significantly lower following Photo-Dynamic Diagnosis (PDD) assisted TURBT compared with good quality white light TURBT (GQ-WLTURBT) - a prospective controlled study : B7
Presence of residual disease at early re-TURBT is halved with complete PDD-TURBT compared with good quality white light TURBT (GQ-WLTURBT) and can be predicted by primary tumour features : B8
Challenging urological guidelines - assessing the yield from early re-resections in a contemporary cohort of patients managed with initial transurethral resection (TURBT) by a specialist bladder cancer team : B9
Contemporary oncological and non-oncological outcomes after radical cystectomy with and without ERAS (Enhanced Recovery After Surgery) for urothelial carcinoma (UC) : B10
Development and implementation of an Enhanced Recovery Programme (ERP) for cystectomy : B11
'Is concomitant carcinoma in situ a relative contraindication to neoadjuvant chemotherapy for muscle invasive TCC bladder' : B12
Cytochrome P450 activity may discriminate a subpopulation with better than expected survival among muscle invasive bladder cancer patients : B13
What factors influence medical students career choice? : C1
Collecting feedback on consultants’ communication skills. A pilot test amongst urology consultants : C2
Undergraduate urology: does it prepare doctors adequately? : C3
Are foundation doctors ready to manage patients in urinary retention? : C4
Workplace based assessments, are we using them well? : C5
An audit of UK trainees' exposure to dedicated infertility training: how good is that training? : C6
Ranking of urology registrar placements within a region. An SAC pilot : C7
Who sees what in outpatients? : C8
Are urology trainees cost-effective to NHS trusts? : C9
Operative experience in urology at CCT 2007-2010 : C10
Holmium Laser Enucleation of the Prostate (HoLEP) in the octo- and nonagenarian: an evaluation of surgical outcome and quality of life : P1
Photovaporisation of the prostate: is it effective in prostates over 100 cc? : P2
Incidence of erectile dysfunction and retrograde ejaculation following Thulium: yttrium-aluminium-garnet laser prostate vaporesection for bladder outlet obstruction: a retrospective study : P3
GreenLight HPS laser prostatectomy is safe and gives excellent functional results with medium term follow up - aprospective international multicentre study : P4
Post-prostatectomy incontinence management: delivery of a specialised service : P5
Significance of upper tract abnormalities identified on ultrasound during follow up of neurogenic bladder patients : P6
Phase 3 efficacy and safety study of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity : P7
The effect of suprapubic catheterization on vesico-ureteric reflux in spinal cord injured patients : P8
Does suprapubic catheter insertion improve quality of life in neuropathic patients? : P9
Histological comparison of ketamine associated bladder destruction with bladder pain syndrome/interstitial cystitis : P10
Urethroplasty for full length anterior urethral stricture disease secondary to lichen sclerosis (LS): a combined one stage bulbar and two stage penile approach using oral mucosa : P11
A patient-reported outcome measure for urethral stricture surgery : P12
Non-transecting bulbar anastomotic urethroplasty: 1 year outcome : P13
The outcome of re-do perineal urethroplasty : P14
Repeated botulinum toxin injections for patients with refractory overactive bladder syndrome : P15
Intravesical botulinum toxin: is it a long-term treatment for DO? : P16
An initial experience of sacral neuromodulation: indications and outcomes : P17
The uses and outcome of the Martius fat pad in female urology : P18
Pelvic organ prolapse: the realm of the urologist : P19
Distinct urodynamic patterns of female bladder outlet obstruction : P20
Re-operation following TVT: indications and outcomes : P21
Male sling for post-prostatectomy Stress Urinary Incontinence (SUI) - medium term results in a single UK centre : P22
Comparison of the performance of the non-invasive cuff test with the gold standard for diagnosing bladder outlet obstruction, pressure flow studies : P23
c-Kit receptor is expressed by a distinct cell population in human urothelium : P24
Mechanisms of development of ketamine- induced cystitis (KIC) : P25
The identification, internal validation and external validation of a biomarker panel to distinguish between significant and insignificant Gleason score in prostate cancer : P26
Circulating microRNAs: novel biomarkers for prostate cancer in the screening setting : P27
Biobanking of tissue obtained fro robotic-assisted radical prostatectomy can be successfully implemented to provide sufficient prostate tissue for RNA studies : P28
Simultaneous profiling of multiple genes in archival diagnostic prostate cancer needle biopsies : P29
Expression analysis of endogenous signalling regulators in archival diagnostic biopsies identifies differential expression of Spred 1 and 2 in prostate cancer : P30
Secondary circulating prostate cells after radical prostatectomy predict biochemical failure and express P504S : P31
Multiphoton microscopy provides virtual histology in human radical prostatectomy specimens : P32
In silico prediction of androgen response elements in metalloproteinase genes : P33
C-MYC induction of Hes6 activates a distinct transcriptional network driving androgen insensitive prostate cancer : P34
WAVE-3 knock-down results in reduced invasion and motility in prostate cancer cells via reduced MMP-2 expression : P35
Identification of the chemotherapy resistant renal cell carcinoma side population: sunitinib sensitisation to paclitaxel treatment via MDR efflux pump pathways : P36
Ki67 expression in penile squamous cell carcinoma : P37
Correlation of National Institute of Health and Clinical Excellence (NICE) 'low-risk' prostate cancer (CaP) in Britain with radical prostatectomy specimens. Is active surveillance in our population realistic? : P38
A nomogram can predict upgrading or upstaging in patients that fit conventional active surveillance criteria : P39
LDR brachytherapy in men <55 yrs is effective and well tolerated : P40
Size doesn't matter; at least not with real time prostate brachytherapy : P41
History of TUR(P) does not prevent satisfactory prostate brachytherapy implant : P42
Robotic prostatectomy delivers excellent outcomes and short hospital stay. Access in the NHS should be expanded not limited due to consumable costs : P43
Comparative oncologic analysis of open versus robotic-assisted radical prostatectomy matched by D'Amico risk category : P44
Hybrid LESS radical prostatectomy: a step closer to pure single port surgery : P45
Misrepresentation of functional outcome after radical prostatectomy : P46
Comparative oncologic effectiveness of open versus robotic-assisted radical prostatectomy in patients with pT3 disease : P47
Does half-life of PSA clearance post radical prostatectomy improve selection of patients for adjuvant therapy? : P48
An update on salvage cryotherapy for recurrent prostate cancer - a prospective case series of 215 patients : P49
Efficacy of diethylstilboestrol in advanced prostate cancer : P50
Diethylstilboestrol in castrate resistant prostate cancer - is it worth the risk? : P51
Surgically significant skeletal events in prostate cancer patients treated with androgen deprivation therapy in England : P52
Current management of the T1 renal mass in a UK Cancer Network : P53
Active surveillance of small renal masses offers short-term oncologic efficacy equivalent to radical and partial nephrectomy : P54
The renaissance of renal biopsy creates a welcome diagnostic tool in our management of renal tumours : P55
Prevalence of papillary renal cell carcinoma in patients with radiologically complex renal cystic lesions (Bosniak IIF and more): 10 years single centre experience : P56
Cryoablation for small renal masses: a single centre experience 2004-2010 : P57
Predicting renal function after nephrectomy : P58
Tumour recurrence after open partial nephrectomy (OPN) for renal cancer (RCC) - lessons learnt from up to 11 years of follow-up : P59
Oncological outcomes from laparoscopic nephrectomy for pT3/4 renal cell cancer : P60
Do neoadjuvant tyrosine-kinase inhibitors affect the surgical outcome in patients undergoing open radical nephrectomy? - A single institution experience : P61
Surgery for loco-regional recurrence after nephrectomy for renal cell carcinoma (RCC): outcomes after initial incomplete resection and implantational recurrences : P62
Nurse versus physician-led transrectal ultrasound guided biopsies: outcome analysis of introduction into standard clinical practice : P63
Transperineal sector biopsies in clinical practice : P64
Distribution of prostate cancer on template prostate mapping (TPM) biopsies in men with low volume prostate cancer on transrectal ultrasound (TRUS) biopsies : P65
Restaging transperineal template prostate biopsies significantly alter the proportion of men who continue on active surveillance : P66
Urological complications and 30 day hospital admission rate of TRUS guided biopsies in men suspected of prostate cancer: population based study : P67
Single dose versus three-day antimicrobial prophylaxis for TRUS guided prostate biopsy: Risk of sepsis and readmission rates : P68
Accuracy of standard MRI in staging prostate cancer : P69
Implications of using multi-parametric MRI as a triage test for men with a raised PSA - a real life practice study : P70
Multi-parametric MRI for selection of suitability for active surveillance in prostate cancer : P71
Influence of social deprivation on referral pattern and rates of radical prostatectomy for early localised prostate cancer in England : P72
Correlating ureteroscopic assessment with final nephroureterectomy histopathology in patients with upper-tract transitional cell carcinoma : P73
Diagnosis of upper and lower urinary tract transitional cell carcinoma (TCC) using oral 5-Aminolevulanic acid (5-ALA) and photodynamic diagnosis (PDD): Prospective cohort study : P74
Long-term endoscopic management of upper tract TCC (UTTCC): 20-year single centre experience : P75
Conservative management of pelviureteric junction obstruction (PUJO): is it appropriate and if so how long is follow-up needed? : P76
Is routine diuresis renography indicated after pyeloplasty? : P77
Addressing the complexity of managing renal Angiomyolipomata: how effective is embolisation? : P78
Incidental diagnoses in CT Urogram - a study of 801 patients : P79
PVP - 5 year follow-up from a UK DGH : P80
Testicular torsion: how do you fix yours? : P81
Sepsis post transrectal ultrasound guided prostate biopsy with standardised ciprofloxacin prophylaxis: an audit of 3 years, 5 surgeons and just over 1200 patients : P82
Estimation of clinically relevant prostate volumes by digital rectal examination - a comparative study : P83
Efficacy of skin stretching and potent topical corticosteroid cream application for phimosis in adult men : P84
Diagnostic flexible cystoscopy in patients under the age of 40: is there an indication? : P85
Flexible cystoscopy: is this investigation of value in patients with urinary tract infection? : P86
Management of recurrent urinary tract infection (rUTI) in females: initial findings from a 'one stop' cystitis clinic : P87
UK urologists' management of secondary azoospermia following previous vasectomy : P88
Urinary lysine, arginine and ornithine may be better predictors of cystine stone formation than urinary cystine and urinary cystine crystals : P89
Retrograde endoscopic lithotripsy as alternative to PCNL in selected patients with large renal calculi : P90
Multi-length ureteric stents are not associated with more symptoms than 24 cm long ureteric stents: a prospective, multicentre randomised controlled trial : P91
Has urinary calculus composition altered over the past 16 years: an analysis of over 50000 stones : P92
Treatment of renal colic with papaverine hydrochloride: a prospective double blind randomized study : P93
Home urinary pH monitoring: a cost-effective option? : P94
Ureteroscopy for acute, symptomatic ureteric stones : P95
Flexible ureteroscopy (URS) and laser lithotripsy of renal stones - the method of choice for stones >1 cm? : P96
An evaluation of the indications and outcomes of renal embolisation in different settings : P97
The evaluation of CT urography in the haematuria clinic : P98
Narrow band imaging cystoscopy improves the detection of bladder cancer : P99
Prostate tumour identification using a force-sensitive rolling indentation probe : P100
TrUST (transplant ureteric stent trial): early versus Standard removal. A randomised controlled trial - the pilot data : P101
A comparison of oncologic outcomes from interfascial and intrafascial nerve sparing robotic-assisted radical prostatectomy : P102
A meta-analysis of 110,016 patients undergoing open retropubic, laparoscopic, and robotic-assisted radical prostatectomy comparing positive surgical margin and complication rates : P103
Pathological outcomes of a 'grades of nerve sparing' concept during roboticassisted radical prostatectomy : P104
Oncologic outcomes of open versus robotic-assisted radical prostatectomy for high-risk prostate cancer: a multiinstitutional study of 13,567 men : P105
Initial experience with a randomised controlled trial of open, robotic, and laparoscopic (CORAL) radical cystectomy: an interim report : P106
Laparoscopic nephrectomy in patients with autosomal dominant polycystic kidney disease : P107
Fresh frozen cadaveric training - an overview of modern surgical/laparoscopic training : P108
*Brighter scope for endourology' - the story of Karl from Tuttlingen : U1
Anderson Hynes pyeloplasty - the gold standard : U2
Professor Ludwig Rein (1849-1930): discovery of an 'occupational cancer' : U3
From battlefield to modern day - a historical review of catheter management in spinal cord injured patients over the last century : U4
Say yes to 'NO': the discovery of nitric oxide and the treatment of erectile dysfunction : U5
The etymology of proteus: an evolution from mythology and history to present day : U6
Professor Ludwig Guttmann - transforming the urological care of spinal injured patients : U7
The urinary catheter - 2000 BC to 2000 AD : U8
Fournier's Gangrene before Fournier : U9
Eponymous Anonymous: the men behind the names : U10
The development and evolution of suburethral sling surgery : U11
The Chimney Sweeper's Cancer: contributions of Sir Percival Pott : U12
Evolution of the catheter - from onion plant to the modern era and beyond : U13
A UK perspective on the development and history of percutaneous nephrolithotomy (PCNL) : U14
An encyclopaedia of the images on the art of uroscopy : U15
Weigert-Meyer Rule: a historical perspective : U16
In search of giants: John Hunter, venereal disease and a noble failure : U17
The evolution of adrenal surgery : U18
Reginald Harrison (1837-1908): pioneering urologic discoveries in late 19th century England : U19
Chronology of LASER in urology : U20
History of male circumcision in Africa: from ritual to lifesaver? : U21
Prison break: urological diseases aboard convict ships in the 19th century : U22
Plugging the hole? The history of the use of haemostatic agents and sealants in urology : U23
A historical evaluation of the changes in prostate cancer diagnosis over eight decades : U24